echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The pharmaceutical's executives have changed! A group of new appointments and a group of resignations

    The pharmaceutical's executives have changed! A group of new appointments and a group of resignations

    • Last Update: 2022-12-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, Jiashi Hall issued an announcement on the completion of the election of the board of directors and the board of supervisors and the appointment of senior management, according to the announcement, the company elected 6 non-independent directors and 3 independent directors of the seventh board of directors, which jointly formed the seventh board of directors; Five shareholder representative supervisors of the seventh session of the Board of Supervisors were elected, and together with the three employee representative supervisors elected by the employee representative meeting held on November 21, 2022, they jointly formed the seventh session of the Company's Board of Supervisors for a term of three years, starting from the date
    of deliberation and approval of the second extraordinary general meeting of shareholders in 2022.

     
    After this election, Mr.
    Chen Changhong, Mr.
    Sun Jianxin and Mr.
    Xu Shuai will no longer serve as directors; Mr.
    Jia Hong, Ms.
    Bai Hongyan, Mr.
    Han Weidong and Mr.
    Zhang Liang no longer hold the position
    of supervisors.

     
    According to the appointment of senior management of the company, the first meeting of the seventh board of directors of the company appointed Mr.
    Huang Yibin as the president of the company; Ms.
    Shen Fang, Mr.
    Lin Jun (responsible for financial work), Mr.
    Wang Wending and Mr.
    Wang Peng were appointed as vice presidents of the company; Ms.
    Hong Jie was appointed as Assistant
    to the President.
    The term of office of the above-mentioned executives shall be from the date of deliberation and approval at the first meeting of the seventh board of directors of the Company to the expiration of the term of office of the seventh board of directors
    .

     
    According to the relevant resume, Mr.
    Huang Yibin has served as the director and executive director of Jiahe Jiashi Pharmaceutical Logistics Co.
    , Ltd.
    since September 2008; From August 2013 to February 2019, he served as the assistant to the president of Jiashitang Pharmaceutical Co.
    , Ltd.
    ; From February 2019 to August 2021, he served as the vice president of Jiashitang Pharmaceutical Co.
    , Ltd.
    ; Since August 2021, he has served as the president of
    Jiashitang Pharmaceutical Co.
    , Ltd.

     
    Ms.
    Shen Fang used to be a salesman and sales manager of Beijing Zhongji Pharmaceutical Operation Company; Sales Director of Hospital Department of Sinopharm Group Pharmaceutical Co.
    , Ltd.
    ; Since April 2012, he has served as the vice president of
    Jiashitang Pharmaceutical Co.
    , Ltd.

     
    Mr.
    Lin Jun has served as the vice president of
    JiaShitang Pharmaceutical Co.
    , Ltd.
    since November 2022.
    Previously, he served as the accountant of the finance department of China Youth Travel Service Headquarters, the manager of the investment management department of the finance department of CYTS Holdings Co.
    , Ltd
    .
    , the financial director of the travel service branch, the assistant to the general manager of the investment management department, the deputy general manager of the finance department, the assistant director of the capital operation headquarters, and the general manager of the asset management department.

     
    Mr.
    Wang Wending began to serve as an employee of the securities department of Jiazhitang Pharmaceutical Co.
    , Ltd.
    in July 2011, and since then he has also served as the assistant manager and securities affairs representative of the securities department of Jiazhitang Pharmaceutical Co.
    , Ltd.
    , the deputy manager of the company's securities department, the representative of securities affairs, the manager of the company's high-value consumables business department, the manager of the securities department, the securities affairs representative, and the director of the company's high-value consumables division, the manager of the securities department and the securities affairs representative; Since August 2021, he has served as the vice president
    of the company.

     
    Mr.
    Wang Peng has served as the director of the purchasing department of Jiashitang Pharmaceutical Co.
    , Ltd.
    since April 2011; Since August 2021, he has served as the vice president of
    Jiashitang Pharmaceutical Co.
    , Ltd.
    Previously, he served as the sales manager of Taiyuan Pharmaceutical Factory of Sinopharm Group, sales of Huayu (Wuxi) Pharmaceutical Co.
    , Ltd.
    , sales of Shanxi Yuandakang Pharmaceutical Co.
    , Ltd.
    , and purchasing manager
    of Keyuan Xinhai Pharmaceutical Co.
    , Ltd.

     
    Ms.
    Hong Jie used to be the secretary of the general manager, the sales manager of the marketing department and the national marketing director of Beijing Guangming Institute of Traditional Chinese Medicine Burn Trauma; Manager of Sales Department and Assistant General Manager of Beijing Tianxing Puxin Biopharmaceutical Co.
    , Ltd.
    ; Deputy Director of the Operation Management Department of Sinopharm Beijing Co.
    , Ltd.
    ; Manager of Sales Department of Beijing Tianxing Puxin Biomedical Co.
    , Ltd.
    ; He served as the sales director of Jiashitang Pharmaceutical Co.
    , Ltd.
    in January 2011 and the assistant
    to the president of the company since April 2012.

     
    According to the data, Jiashitang is the main platform of Everbright Health Business Sector, and the company's business is mainly divided into three sectors
    : pharmaceutical wholesale, pharmaceutical logistics and pharmaceutical chain.

     
    According to the third quarterly report of 2022, in the first three quarters, Jiashitang achieved revenue of 20.
    281 billion yuan, a year-on-year increase of 4.
    81%; The net profit was 247 million yuan, down 6.
    96%
    year-on-year.

     
    Disclaimer: Under no circumstances does the information or opinions expressed herein constitute investment advice
    to anyone.

     
    ={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
    appendChild(createElement('script')).
    src='http://bdimg.
    share.
    baidu.
    com/static/api/js/share.
    js?v=89860593.
    js?cdnversion='+~(-new Date()/36e5)];
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.